The Neurology/Ophthalmology course (NEU-5501) of the Advanced Stem Cell Education Program is designed to teach healthcare professionals how stem cell therapies have given new hope for patients suffering from Huntington’s, Parkinson’s, spinal cord injuries, strokes, and age-related macular degeneration. Neurological disorders include any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Until recently, interventions for neurological disorders included physiotherapy, Neuro-rehabilitation, pain management, medication, or neurosurgery.
The retina, like many other regions of the nervous system, is subject to various inherited and acquired degenerative conditions. One of the most common is age-related macular degeneration (AMD). AMD retinal changes are present in approximately 10% of people older than 65 and as many as one in three people older than 80.
The utilization of induced pluripotent stem cells (which have all the same properties as embryonic stem cells, can be grown indefinitely in vitro and can form virtually any cell in the body, including nerves, retinal photoreceptors and retinal pigment epithelial cells) have shown great promise in the treatment of these disorders.
• This is a subspecialty course with a cost of $2500.
• Self-paced open enrollment
• Physician CME Eligible: Yes: 27 CME AMA PRA Category 1 Credits™
• Program includes digital streaming of lectures and PDF resources
• Learn instantly with any computer or laptop with a strong internet connection
• Estimated effort: 5-6 weeks of material, 4-5 hours/week; 4 topic quizzes, final exam
Some background in biology is helpful. This course may contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA. Please consult the prescribing information for each product.
• Biology Of Stem Cells
• Regulation of Stem Cell Therapies